Skip to main content About News Giving All Departments Contact Us Site Map
 University of Texas Southwestern Medical School
 
Search       
Print Friendly  
spacer Home Education Research Patient Care Faculty & Administration Resource Careers

Clinical Trials :: Chemoradiation Therapy for Stage IIIA/IIIB Non-Small Cell Lung Cancer



Ad Title: Chemoradiation Therapy for Stage IIIA/IIIB Non-Small Cell Lung Cancer
Study Title: RTOG 0617, A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel +/- cetuximab in Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer
Protocol Number: 032008-013
Department(s) involved in the Study: Radiation Oncology, Simmons Comprehensive Cancer Center
Purpose of the Study: This is a multi-center randomized phase III study evaluating concurrent and consolidation carboplatin/paclitaxel with either high dose (74 Gy) or standard dose (60 Gy) radiation therapy in patients with locally advanced inoperable stage IIIA/IIIB non small cell lung cancer
Participant Eligibility: Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer who meets the criteria for inclusion. Contact Study Coordinator for more information.
Disease/Condition Under Study: Stage IIIA/IIIB Non-Small Cell Lung Cancer
Cancer Related Study: Yes
Study Drug(s): carboplatin, paclitaxel
Study Device(s):
Study Doctor: Dr. Hak Choy
Location of Study:
Sites Recruiting at this Site
Parkland Memorial Hospital Yes
UT Southwestern University Hospitals St. Paul Building Yes
UT Southwestern University Hospitals Zale Lipshy Building Yes
UT Southwestern Medical Center, Richardson Regional Medical Center Yes
Contact Phone: 214-648-1631
Email: laurin.loudat@Utsouthwestern.Edu
Other Information:
Website Keywords: Hematology, Lung Cancer, Men's Health, Oncology
Medical Keywords: carboplatin, cetuximab, chemotherapy, Non-Small Cell Lung Cancer , paclitaxel, radiation therapy, Stage IIIA/IIIB